Evaluation of Bevacizumab in the Adjuvant Treatment of Colon Cancer Leonard Saltz CLINICAL TRIAL REPORT 01 May 2010 Pages: 109 - 110
Clinical Relevance of Apoptotic Regulatory Proteins in Colorectal Cancers Howard C. MasuokaFrank A. Sinicrope ReviewPaper 14 April 2010 Pages: 111 - 117
Molecular Markers of Chemotherapy Response in Colorectal Cancer Michael S. BraunMatthew T. Seymour ReviewPaper 14 April 2010 Pages: 118 - 125
Strategies for Managing Chemotherapy-Induced Sensory Neuropathy Joleen HubbardAxel Grothey ReviewPaper 20 April 2010 Pages: 126 - 132
Biomarkers for Therapies Directed at Angiogenesis Maria AlsinaManuel Ruiz-EcharriJosep Tabernero OriginalPaper 30 April 2010 Pages: 133 - 143
QUASAR Results: The Prognostic Validity of a Colon Cancer Recurrence Score and the Role of Multigene Profiles in Determining Risk Kakil Ibrahim RasulDavid J. Kerr ReviewPaper 14 April 2010 Pages: 144 - 147
Microsatellite Status and Adjuvant Chemotherapy in Patients with Stage II Colon Cancer Jean-Baptiste BachetPierre Laurent-PuigThierry André ReviewPaper 27 April 2010 Pages: 148 - 157
Interpreting the Inconsistent Data Concerning the Role of 18qLOH as a Prognostic Marker for Colorectal Cancer Monica M. Bertagnolli ReviewPaper 19 May 2010 Pages: 158 - 167
Ongoing Colorectal Cancer Adjuvant Trials in Japan Toshiaki Watanabe OriginalPaper 21 April 2010 Pages: 168 - 174
Erratum to: Curative Approach for Stage IV Colorectal Cancer with Multiorgan Involvement: What Makes Sense and What Doesn’t? Polina KhrizmanMary F. Mulcahy Erratum 01 May 2010 Pages: 175 - 176